Patients should be instructed to clean the injection site with alcohol and allow it to dry before injection
Nov-Dec 2022;103-104:111727
Qsymia clinical trial results Two major phase 3 trials established the efficacy data for Qsymia: The CONQUER trial enrolled 2,487 overweight and obese adults
medical societies, offering structured approaches to follow up care, lifestyle planning, and long term weight management
Safety concerns included uncharacterized immunogenicity risks, inadequate impurity and endotoxin testing in available raw material, the unresolved free-base versus acetate salt form distinction, and, for BPC-157 specifically, an angiogenesis mechanism that raises theoretical concerns for patients with undiagnosed tumors
Although quetiapine is not directly labeled as an antipsychotic in this study, the effects it had both metabolically and on gut bacteria are consistent with what is known about that class of drugs